SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001279569-21-000448
Filing Date
2021-04-12
Accepted
2021-04-12 07:19:29
Documents
18
Period of Report
2021-02-28

Document Format Files

Seq Description Document Type Size
1 FORM 6-K aphria6k.htm 6-K 11848
2 FINANCIAL STATEMENTS ex991.htm EX-99.1 1028948
3 MANAGEMENT'S DISCUSSION AND ANALYSIS ex992.htm EX-99.2 686340
4 CEO AND CFO CERTIFICATES ex993.htm EX-99.3 18025
5 GRAPHIC logo.jpg GRAPHIC 39040
6 GRAPHIC logo_footer.jpg GRAPHIC 6516
7 GRAPHIC mda_7a.jpg GRAPHIC 14409
8 GRAPHIC mda_7b.jpg GRAPHIC 25906
9 GRAPHIC mda_7c.jpg GRAPHIC 24059
10 GRAPHIC mda_7d.jpg GRAPHIC 16727
11 GRAPHIC mda_8a.jpg GRAPHIC 10674
12 GRAPHIC mda_8b.jpg GRAPHIC 22441
13 GRAPHIC mda_8c.jpg GRAPHIC 6558
14 GRAPHIC mda_8d.jpg GRAPHIC 3243
15 GRAPHIC mda_8e.jpg GRAPHIC 16667
16 GRAPHIC mda_10.jpg GRAPHIC 79043
17 GRAPHIC mda_32.jpg GRAPHIC 68715
18 GRAPHIC mda_cover.jpg GRAPHIC 280855
  Complete submission text file 0001279569-21-000448.txt   2594802
Mailing Address 245 TALBOT STREET W., SUITE 103 LEAMINGTON A6 N8H 1N8
Business Address 245 TALBOT STREET W., SUITE 103 LEAMINGTON A6 N8H 1N8 (844) 427-4742
Aphria Inc. (Filer) CIK: 0001733418 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 0531
Type: 6-K | Act: 34 | File No.: 001-38708 | Film No.: 21819364
SIC: 2833 Medicinal Chemicals & Botanical Products